Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients

NCT04809181 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy
Stem Cell Transplant Complications

Interventions

DRUG: Azacitidine in Combination With Venetoclax

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]